Intravenous albumin shortens the duration of hospitalization for patients with hypoalbuminemia and bleeding peptic ulcers: A pilot study

Digestive Diseases and Sciences

Volumn 58, Issue 11, 2013, Pages 3232-3241

  Cheng, Hsiu Chi ^a   Chang, Wei Lun ^a   Chen, Wei Ying ^a   Tsai, Yu Ching ^a   Yeh, Yi Chun ^a   Sheu, Bor Shyang ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Hypoalbuminemia; Length of stay; Omeprazole; Peptic ulcer hemorrhage

Indexed keywords

HUMAN ALBUMIN; OMEPRAZOLE; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENDOSCOPIC THERAPY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYPOALBUMINEMIA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL;

ALBUMINS; HOSPITALIZATION; HUMANS; HYPOALBUMINEMIA; INJECTIONS, INTRAVENOUS; PEPTIC ULCER; PEPTIC ULCER HEMORRHAGE; PILOT PROJECTS;

EID: 84889570686     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-2821-8     Document Type: Article

References (40)

1. Yavorski RT, Wong RK, Maydonovitch C, Battin LS, Furnia A, Amundson DE. Analysis of 3,294 cases of upper gastrointestinal bleeding in military medical facilities. Am J Gastroenterol. 1995;90:568-573.
2. Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol. 1985;90:206-210.
3. Silvertstein FE, Gilbert DA, Tedesco FJ, Buenger NK, Persing J, 277 members of the ASGE. The National ASGE Survey on upper gastrointestinal bleeding. I. Study design and baseline data. Gastrointest Endosc. 1981;27:73-79.
4. Rockall TA, Logan RFA, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996;38:316-321.
5. Katschinski B, Logan R, Davies J, Faulkner G, Pearson J, Langman M. Prognostic factors in upper gastrointestinal bleeding. Dig Dis Sci. 1994;39:6-12.
6. Johnston JH. Endoscopic risk factors for bleeding peptic ulcer. Gastrointest Endosc. 1990;36:S16-S20.
7. Cheng HC, Chuang SA, Kao YH, Kao AW, Chuang CH, Sheu BS. Increased risk of rebleeding of peptic ulcer bleeding in patients with comorbid illness receiving omeprazole infusion. Hepatogastroenterology. 2003;50:2270-2273.
8. Forrest JA, Finlayson ND, Sherman DJ. Endoscopy in gastrointestinal bleeding. Lancet. 1974;2:394-397.
9. Lim CH, Vani D, Shah SG, Everett SM, Rembacken BJ. The outcome of suspected upper gastrointestinal bleeding with 24-hour access to upper gastrointestinal endoscopy: a prospective cohort study. Endoscopy. 2006;38:581-585.
10. Terdiman JP, Ostroff JW. Gastrointestinal bleeding in the hospitalized patient: a case-control study to assess risk factors, causes, and outcome. Am J Med. 1998;104:349-354.
11. Cheng HC, Kao AW, Chuang CH, Sheu BS. The efficacy of high and low dose intravenous omeprazole in preventing rebleeding for patients with bleeding peptic ulcers and comorbid illnesses. Dig Dis Sci. 2005;50:1194-1201.
12. Lau JY, Sung JJ, Lee KK, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med. 2000;343:310-316.
13. Schaffalitzky de Muckadell OB, Havelund T, Harling H, et al. Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers: randomized double-blind placebo-controlled multicentre study. Scand J Gastroenterol. 1997;32:320-327.
14. Sheu BS, Chi CH, Huang CC, Kao AW, Wang YL, Yang HB. Impact of intravenous omeprazole on Helicobacter pylori eradication by triple therapy in patients with peptic ulcer bleeding. Aliment Pharmacol Ther. 2002;16:137-143.
15. Freston JW. Overview of medical therapy of peptic ulcer disease. Gastroenterol Clin N Am. 1990;9:121-140.
16. Kinney JM, Weissmann C. Forms of malnutrition in stressed and unstressed patients. Clin Chest Med. 1986;7:19-28.
17. Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg. 2003;237:319-334.
18. Rady MY, Ryan T, Starr NJ. Clinical characteristics of preoperative hypoalbuminemia predict outcome of cardiovascular surgery. J Parenter Enteral Nutr. 1997;21:81-90.
19. Kung SP, Tang GJ, Wu CW, Lui W. Serum albumin concentration as a prognostic indicator for acute surgical patients. Chin Med J (Taipei). 1999;62:61-67.
20. Hamilton JE, Harbrecht PJ, Robbins RE, Noland JL. The behavior and management of major acute bleeding from peptic ulcers. Surg Gynecol Obstet. 1965;121:545-550.
21. Cheng HC, Chang WL, Yeh YC, Chen WY, Tsai YC, Sheu BS. Seven-day intravenous low-dose omeprazole infusion reduces peptic ulcer rebleeding for patients with comorbidities. Gastrointest Endosc. 2009;70:433-439.
22. Saltzman JR, Tabak YP, Hyett BH, Sun X, Travis AC, Johannes RS. A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding. Gastrointest Endosc. 2011;74:1215-1224.
23. Hyett BH, Abougergi MS, Charpentier JP, et al. The AIMS65 score compared with the Glasgow-Blatchford score in predicting outcomes in upper GI bleeding. Gastrointest Endosc. 2013;77:551-557.
24. Uhing MR. The albumin controversy. Clin Perinatol. 2004;31:475-488.
25. Vincent JL, Navickis RJ, Wilkes MM. Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials. Crit Care Med. 2004;32:2029-2038.
26. Regtien JG, Stienstra Y, Ligtenberg JJ, van der Werf TS, Tulleken JE, Zijlstra JG. Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials. Crit Care Med. 2005;33:915.
27. Martin GS. A new twist on albumin therapy in the intensive care unit, again. Crit Care Med. 2006;34:2677-2679.
28. American Society of Anesthesiologists. New classification of physical status. Anesthesiology. 1963;24:111.
29. Yang CC, Shin JS, Lin XZ, Hsu PI, Chen KW, Lin CY. The natural history (fading time) of stigmata of recent hemorrhage in peptic ulcer disease. Gastrointest Endosc. 1994;40:562-566.
30. Matsui S, Kamisako T, Kudo M, Inoue R. Endoscopic band ligation for control of non-variceal non-ulcer gastrointestinal hemorrhage: comparison with bipolar electrocoagulation. Gastrointest Endosc. 2002;55:214-218.
31. Wang CH, Ma MH, Chou HC, et al. High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: a systematic review and meta-analysis of randomized controlled trials. Arch Intern Med. 2010;170:751-758.
32. Sheu BS, Lin CY, Lin XZ, Shiesh SC, Yang HB, Chen CY. Long-term outcome of triple therapy in Helicobacter pylori-related non-ulcer dyspepsia: a prospective controlled assessment. Am J Gastroenterol. 1996;91:441-447.
33. Sung JJ, Tsoi KK, Ma TK, Yung MY, Lau JY, Chiu PW. Causes of mortality in patients with peptic ulcer bleeding: a prospective cohort study of 10,428 cases. Am J Gastroenterol. 2010;105:84-89.
34. Sung JJ, Tsoi KK, Lai LH, Wu JC, Lau JY. Endoscopic clipping versus injection and thermo-coagulation in the treatment of bleeding non-variceal upper gastrointestinal bleeding: a meta-analysis. Gut. 2007;56:1364-1372.
35. Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper gastrointestinal haemorrhage. Lancet. 2000;356:1318-1321.
36. Zaragoza AM, Tenías JM, Llorente MJ, Alborch A. Prognostic factors in gastrointestinal bleeding due to peptic ulcer: construction of a predictive model. J Clin Gastroenterol. 2008;42:786-790.
37. Wong GL, Wong VW, Chan Y, et al. High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Gastroenterology. 2009;137:525-531.
38. Peters T Jr. Serum albumin. In: Putnam FW (ed) The Plasma Proteins, 2nd edn. New York, NY: Academic Press, 1975:131-181.
39. Regardh CG, Gabrielsson M, Hoffman KJ, Lofberg I, Skanberg I. Pharmacokinetics and metabolism of omeprazole in animals and man-an overview. Scand J Gastroenterol. 1985;108:79-94.
40. Emerson TE Jr. Unique features of albumin: a brief review. Crit Care Med. 1989;17:690-694.